<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03209635</url>
  </required_header>
  <id_info>
    <org_study_id>AI_probiotic_NK</org_study_id>
    <nct_id>NCT03209635</nct_id>
  </id_info>
  <brief_title>Weissella Cibaria JW15 Consumption and NK Cell Activity</brief_title>
  <official_title>Weissella Cibaria JW15 Consumption and NK Cell Activity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A The aim of this study was to investigate the impact of consuming Weissella cibaria (W.
      cibaria) JW15 supplementation isolated from Kimchi, Korea traditional fermented food, on
      natural killer (NK) cell activity and circulating levels of cytokines and immunoglobulin
      (Ig).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, double-blinded, placebo-controlled study was conducted on 100 nondiabetic
      subjects. Over an eight-week testing period, the probiotic group consumed 4 capsules (300
      mg/capsule) containing 1 x 10^10 colony-forming units (cfu) of W. cibaria JW15 each day,
      whereas the placebo group consumed the same product without a probiotic.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2016</start_date>
  <completion_date type="Actual">March 20, 2017</completion_date>
  <primary_completion_date type="Actual">March 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Natural killer cell activity at baseline</measure>
    <time_frame>Baseline</time_frame>
    <description>Natural killer cell activity (%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Natural killer cell activity at 8-week follow up</measure>
    <time_frame>8-week follow up</time_frame>
    <description>Natural killer cell activity (%)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Immune Function</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>4 capsules (300 mg/capsule) containing 52% crystalline cellulose and 46% lactose in identical-looking with test product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Probiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4 capsules (300 mg/capsule) containing each capsule 1.0 x 10^10 colony-forming units (cfu) of Weissella cibaria JW15, twice a day</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>4 capsules (300 mg/capsule) containing 52% crystalline cellulose and 46% lactose in identical-looking with test product</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Probiotic</intervention_name>
    <description>4 capsules (300 mg/capsule) containing each capsule 1.0 x 10^10 colony-forming units (cfu) of Weissella cibaria JW15, twice a day</description>
    <arm_group_label>Probiotic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nondiabetic (fasting serum glucose concentration &lt; 126 mg/dL)

          -  Subjects with 4,000-8,000 leukocyte counts

        Exclusion Criteria:

          -  Constant consumption of any probiotic products

          -  Taking medicine related to inflammation within one month before screening

          -  Allergy to probiotics

          -  Lactose intolerance

          -  Diabetes

          -  History/presence of significant metabolic disease

          -  Acute or chronic disease requiring treatment

          -  Taking any medications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jong Ho Lee, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Food and Nutrition, Colleage of Human Ecology, Yonsei University</affiliation>
  </overall_official>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 4, 2017</study_first_submitted>
  <study_first_submitted_qc>July 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 6, 2017</study_first_posted>
  <last_update_submitted>July 4, 2017</last_update_submitted>
  <last_update_submitted_qc>July 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yonsei University</investigator_affiliation>
    <investigator_full_name>Jong Ho Lee</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

